BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oksi J, Anttila VJ, Mattila E. Treatment of Clostridioides (Clostridium) difficile infection. Ann Med 2020;52:12-20. [PMID: 31801387 DOI: 10.1080/07853890.2019.1701703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fettucciari K, Marconi P, Marchegiani A, Fruganti A, Spaterna A, Bassotti G. Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile. Therap Adv Gastroenterol 2021;14:17562848211032797. [PMID: 34413901 DOI: 10.1177/17562848211032797] [Reference Citation Analysis]
2 Ma KGL, Lertpiriyapong K, Piersigilli A, Dobtsis I, Wipf JRK, Littmann ER, Leiner I, Pamer EG, Ricart Arbona RJ, Lipman NS. Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 Clostridioides difficile in Highly Immunocompromised Strains of Mice. Comp Med 2020;70:277-90. [PMID: 32404234 DOI: 10.30802/AALAS-CM-19-000109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kounatidis D, Vadiaka M, Kouvidou C, Sampaziotis D, Skourtis A, Panagopoulos F, Konstantinou F, Vallianou NG. Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review. Rheumatol Int 2020;40:997-1000. [PMID: 32318801 DOI: 10.1007/s00296-020-04586-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Monma T, Iwamoto J, Honda A, Ueda H, Kakizaki F, Yara S, Miyazaki T, Ikegami T. Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile. Metabolites 2022;12:331. [DOI: 10.3390/metabo12040331] [Reference Citation Analysis]
5 Jachowicz E, Pac A, Różańska A, Gryglewska B, Wojkowska-Mach J. Post-Discharge Clostridioides difficile Infection after Arthroplasties in Poland, Infection Prevention and Control as the Key Element of Prevention of C. difficile Infections. Int J Environ Res Public Health 2022;19:3155. [PMID: 35328843 DOI: 10.3390/ijerph19063155] [Reference Citation Analysis]
6 Gruber P, Hoppe V, Grochowska E, Paleczny J, Junka A, Smolina I, Kurzynowski T. Material Extrusion-Based Additive Manufacturing of Poly(Lactic Acid) Antibacterial Filaments-A Case Study of Antimicrobial Properties. Polymers (Basel) 2021;13:4337. [PMID: 34960888 DOI: 10.3390/polym13244337] [Reference Citation Analysis]